A comprehensive view of Orthopedics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Grunenthal's injectable Resiniferatoxin gets breakthrough therapy designation from FDA for knee osteoarthritis pain; knee osteoarthritis is a progressive condition affecting over 360 million people worldwide
Published: May 22, 2023 by PR Newswire
Abbott receives FDA approval for its spinal cord stimulation systems to treat chronic back pain in people who have limited surgical options; more than 50 million people in the US suffer from chronic pain
Published: May 16, 2023 by PR Newswire
Amgen sues Novartis' Sandoz over biosimilar candidate for bone meds Prolia and Xgeva, alleging insufficient manufacturing process details and potential patent infringement
Published: May 05, 2023 by FiercePharma
Joint pain injections market projected to reach US$9.20B by 2030, with CAGR growth of 8.6% from 2022-2030; growth driven by rise in osteoarthritis and musculoskeletal illnesses, increased patient awareness of this treatment option
Published: May 01, 2023 by Fortune Business Insights
Novartis Pharmaceuticals lists new Phase 2 clinical trial to study safety and efficacy of RHH646 for knee osteoarthritis
Published: April 19, 2023 by Contify Life Science News

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count